These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors. Crook ED; Preddie DC Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155 [TBL] [Abstract][Full Text] [Related]
5. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
6. [ACE inhibitors and early diabetic nephropathy]. Bangstad HJ; Hartmann A; Berg TJ; Hanssen KF Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3039-41. PubMed ID: 7570536 [TBL] [Abstract][Full Text] [Related]
7. Bradykinin B2 receptors as a target in diabetic nephropathy. Doggrell SA Curr Opin Investig Drugs; 2006 Mar; 7(3):251-5. PubMed ID: 16555685 [TBL] [Abstract][Full Text] [Related]
8. An evidence-based review of ACE inhibitors in incipient diabetic nephropathy. Haider A; Oh P; Peloso PM Can J Clin Pharmacol; 2000; 7(2):115-9. PubMed ID: 10958708 [TBL] [Abstract][Full Text] [Related]
9. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Ravid M; Lang R; Rachmani R; Lishner M Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838 [TBL] [Abstract][Full Text] [Related]
10. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists]. Tesar V Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease. Cantarovich F; Rangoonwala B Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572 [TBL] [Abstract][Full Text] [Related]
12. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients. Cooper ME J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]